AquaBounty Technologies converted all outstanding Series A (263,753 shares) and Series B (109,223 shares) Preferred Stock into an aggregate of 8,077,043 shares of Common Stock. The conversion was triggered by the SEC declaring the company's Form S-3 registration statement effective on October 23, 2026. Post-conversion, no preferred stock remains outstanding and total common shares increased to 13,291,953. AquaBounty Technologies develops genetically modified salmon for aquaculture.
